Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05150860 · ClinicalTrials.gov registry record · NA
Communities Fighting COVID Return to School
A NA study, sponsored by San Diego State University.
- Completed
- Registry status
- NA
- Development phase
- 852
- Enrollment target
NCT05150860: Completed NA study, sponsored by San Diego State University.
NCT05150860 is a NA study that has completed, run by San Diego State University. The registered enrollment target is 852 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05150860, a NA study, has completed, sponsored by San Diego State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 852 participants
- Enrollment target
Study Summary
San Diego State University (SDSU), a designated Hispanic-serving institution, is partnering with Sweetwater Union High School District, an independent public school district serving 90% ethnic minority and a high proportion of socioeconomically disadvantaged students, and other community partners, to generate evidence for effective and feasible COVID-19 testing for unvaccinated and medically vulnerable middle school students and staff as part of broader COVID mitigation strategies including vaccination to return students back to school safely.
Primary Outcome
Proportion of scheduled weekly COVID-19 tests completed when enrolled in the trial
Interventions
- BEHAVIORAL At-home COVID-19 testing
- BEHAVIORAL Onsite COVID-19 testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 852 participants |
| Start Date | 2021-10-17 |
| Est. Completion | 2022-04-02 |
| Phase | NA |
What the finished NCT05150860 record still lists
NCT05150860 is an interventional study that assigns participants to a tested intervention. The registered 852 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 2 interventions - of which At-home COVID-19 testing is the first listed.
NCT05150860 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05150860 about?
NCT05150860 is a clinical study titled "Communities Fighting COVID Return to School". San Diego State University (SDSU), a designated Hispanic-serving institution, is partnering with Sweetwater Union High School District, an independent public school district serving 90% ethnic minority and a high proportion of socioeconomically disadvantaged students, and other community partners, t...
What is the current status of trial NCT05150860?
This trial is currently completed. It is a NA study. The enrollment target is 852 participants. The study started on 2021-10-17. Estimated completion is 2022-04-02.
What interventions are being tested in trial NCT05150860?
The interventions under investigation include: At-home COVID-19 testing (BEHAVIORAL), Onsite COVID-19 testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05150860?
This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05150860's enrollment target sits among peer trials
852 131st of 2000 higher than 1,870 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06237452 · 852 participants · Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
- NCT06422143 · 851 participants · Phase 3
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
- NCT07005102 · 854 participants · Phase 2
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- NCT07290491 · 854 participants · Phase 3
Spiritual Care or Psychotherapy Versus Palliative Care Alone in Patients With Non-Curative Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI